FDA Investigator Michael C Zubelewicz
Michael C Zubelewicz has conducted inspections on 7 sites in 1 countries as of 21 Feb 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
21 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Michael C Zubelewicz:
Alan E Mehl,
Alan L Truong,
Alan M Barker,
Ashley A Mutawakkil,
Bei Y He,
Brittany D Terhar,
Carl A Huffman, III,
Chilton L Ng,
Chris A Sack,
Conner N Mann,
Cynthia M Goudeau,
Dana D Carter, SR DDS,
Danial S Hutchison,
David J Eide,
Derrionna M Epps,
Diane L Raccasi,
Dustin K Hampton,
Eric C Nielsen,
Eric M Padgett,
Erika V Butler,
Farhana Khan,
Gloria J Champagne,
Gretchen Lf Trendel,
Gwyn G Dickinson,
J Michael Cannon, PhD,
James I Giefer,
James K Rice,
Jeffrey B Moody,
Jill J Tillman,
Jimmie L Weigand,
José E Meléndez,
Joseph R Lambert,
Karen C Daugherty,
Karen M Montgomery (KMM),
Kellia N Hicks,
Laura S Huffman,
Linda F Murphy,
Lisa L Flores,
Lisa L Gilliam,
Lisa R Hilliar,
Logan T Williams,
Marcus F Yambot,
Marion D Wimberly, Jr,
Mary L Schuckmann,
Matthew M Schuckmann,
Matthew Schuckman,
Megan T Ziegler,
Melissa M Steiger,
Michele L Obert,
Michele Perry Williams,
Monica E Murie,
Neal L Adams,
Rita K Kabaso,
Robert J Ham,
Robin K Reel,
Ross J Grigsby,
Shafiq S Ahadi,
Shirley J Berryman,
Sri Ramakrishnaiah Yellela, PhD,
Srinivas R Chennamaneni, PhD,
Steven D Kehoe,
Susanna E Ford,
Tamara J Umscheid,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Thomas J Arista,
Torrey M Ward,
Veronica Fuentes, MS,
Victoria A Wagoner,
Victoria P Quadrini,
Vikas Moolchandani,
Warren J Lopicka,
Wayne D Mcgrath,
Xiaohan Cai, PhD,
Yiyue Zhang (nmi), PhD,
Zachary A Bogorad
Michael C Zubelewicz's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2022 | FDA 483 | TriRx Shawnee LLC - Form 483, 2022-12-14 |
February, 2022 | FDA 483 | Sterling Pharmaceutical Services, LLC - Form 483, 2022-02-18 |
March, 2022 | FDA 483 | Eco Lips, Inc. - Form 483, 2022-03-24 |
February, 2022 | FDA 483 Response | Sterling Pharmaceutical Services, LLC - Form 483R, 2022-03-14 |
February, 2023 | FDA 483 | Chemdex, Inc - Form 483, 2023-02-27 |
March, 2022 | FDA 483 | R. N. Eaton & Company, Inc. - Form 483, 2022-03-02 |
September, 2022 | FDA 483 | S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2022-09-14 |
June, 2022 | FDA 483 | Aquascience Technologies & Research, Inc - Form 483, 2022-06-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more